IP Verse

Ferring competitive analysis

Latest publications and patents of Ferring New

Explore the latest publications and patents granted to Ferring, showcasing their recent innovations and technological advancements.

Last updated on: Oct 1, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Ferring

EP2854831
Jul 10, 2024Manufacture Of DegarelixGranted And Under Opposition
EP3784210
Mar 13, 2024Topical Pharmaceutical Composition For Treatment Of Anal Fissures And HemorrhoidsGranted And Under Opposition
EP3222272
Nov 3, 2021Pharmaceutical CompositionGranted And Under Opposition
EP3144318
Sep 23, 2020Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-SialylationOpposition Rejected
EP2292252
Aug 7, 2019Unitary Combination Of Fsh And HcgRevoked
EP2424503
Jul 5, 2017Composition For The Treatment Of Prostate CancerOpposition Rejected
EP3045471
Mar 29, 2017Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-SialylationRevoked

Latest oppositions filed by Ferring

Explore patent oppositions filed by Ferring against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3278809
Safe Desmopressin AdministrationALLERGANAug 20, 2020
EP2854790
Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture MediaARES TRADINGMay 14, 2019
EP2381923
Safe Desmopressin AdministrationACERUS PHARMACEUTICALS USAMay 1, 2019
EP2164877
The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein ProductionMERCK SERONOSep 4, 2018
EP2442821
Safe Desmopressin AdministrationACERUS PHARMACEUTICALS USAMar 12, 2018

Latest patents of Ferring opposed by its competitors

Explore Ferring's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2854831
Jul 10, 2024Manufacture Of Degarelix4
EP3784210
Mar 13, 2024Topical Pharmaceutical Composition For Treatment Of Anal Fissures And Hemorrhoids1
EP3222272
Nov 3, 2021Pharmaceutical Composition1
EP3144318
Sep 23, 2020Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation1
EP2292252
Aug 7, 2019Unitary Combination Of Fsh And Hcg1
EP2424503
Jul 5, 2017Composition For The Treatment Of Prostate Cancer1
EP3045471
Mar 29, 2017Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-Sialylation1

Latest PTAB cases involving Ferring

Discover the latest PTAB cases involving Ferring, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ferring with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
FERRING510 - - Balanced
ALLERGAN11281333Balanced
MERCK SERONO23 - 4Defensive
SERENITY PHARMACEUTICALS - 3 - - Non-Active